Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma : CALGB 90207ROSENBERG, J. E; HALABI, S; SANFORD, B. L et al.Annals of oncology. 2008, Vol 19, Num 5, pp 946-950, issn 0923-7534, 5 p.Article

A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma : results of the Cancer and Leukaemia Group B 90102PHILIPS, George K; HALABI, Susan; SANFORD, Ben L et al.BJU international (Papier). 2008, Vol 101, Num 1, pp 20-25, issn 1464-4096, 6 p.Article